ProMIS Neurosciences, Inc. (PMN)

NASDAQ: PMN · IEX Real-Time Price · USD

1.990

-0.140 (-6.57%)

At close: Jul 19, 2024, 4:00 PM

2.110

+0.120 (6.03%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

ProMIS Neurosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	6.47	6.38	7.29	3.66	2.03
Research & Development	6.5	7.88	16.09	4.63	2.22
Operating Expenses	12.97	14.26	23.38	8.29	4.25
Operating Income	-12.97	-14.26	-23.38	-8.29	-4.25
Interest Expense / Income	0.28	0.2	0.28	0.42	0
Other Expense / Income	-1.36	-1.25	-5.6	1.08	-0
Pretax Income	-11.89	-13.21	-18.06	-9.79	-4.25
Net Income	-11.89	-13.21	-18.06	-9.79	-4.25
Shares Outstanding (Basic)	20	12	8	6	5
Shares Outstanding (Diluted)	20	12	8	6	5
Shares Change	127.69%	63.85%	29.68%	21.55%	-
EPS (Basic)	-0.74	-1.07	-2.41	-1.69	-0.89
EPS (Diluted)	-0.74	-1.07	-2.41	-1.69	-0.89
Free Cash Flow	-18.57	-10.84	-17.04	-9.21	-3.31
Free Cash Flow Per Share	-0.95	-0.88	-2.27	-1.59	-0.70
EBITDA	-11.59	-12.99	-17.77	-9.33	-4.24
Depreciation & Amortization	0.02	0.02	0.01	0.05	0.01
EBIT	-11.61	-13.01	-17.78	-9.37	-4.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).